Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease characterized by chronic symmetrical erosive synovitis and extra-articular manifestations, including interstitial lung disease (ILD), whose treatment is nowadays challenging due to high infectious risk and possible pulmonary iatrogenic toxicity.Janus kinase inhibitors, namely, tof